All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @rahjawilliamss on TikTok · 175s|Watch on TikTok

Can lifting weights really save your butt on weight loss drugs?

rahjawilliamss

TikTok creator

52.6K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists like semaglutide and tirzepatide cause 15-21% body weight loss in clinical trials, with 25-30% of that loss coming from lean muscle mass. Resistance training can reduce muscle loss to 10-15% of total weight reduction when combined with adequate protein intake.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Can lifting weights really save your butt on weight loss drugs?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Can lifting weights really save your butt on weight loss drugs? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Can lifting weights really save your butt on weight loss drugs?" from rahjawilliamss. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide and tirzepatide cause 15-21% body weight loss in clinical trials, with 25-30% of that loss coming from lean muscle mass.

The reason this review is not generic is the source wording and the canonical claim label "glp1 lift weights to not lose your butt learnontiktok weightl." In this clip, the useful excerpt is: "Lift Weights To Not "Lose Your Butt"" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Resistance training can reduce muscle loss from 25% to 10-15% of total weight reduction
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists like semaglutide and tirzepatide cause 15-21% body weight loss in clinical trials, with 25-30% of that loss coming from lean muscle mass.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists like semaglutide and tirzepatide cause 15-21% body weight loss in clinical trials, with 25-30% of that loss coming from lean muscle mass. Resistance training can reduce muscle loss to 10-15% of total weight reduction when combined with adequate protein intake.
  • GLP-1 medications cause 25-30% of weight loss to come from lean muscle mass in major trials
  • Resistance training can reduce muscle loss from 25% to 10-15% of total weight reduction

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GLP-1 medications cause 25-30% of weight loss to come from lean muscle mass in major trials
  • Resistance training can reduce muscle loss from 25% to 10-15% of total weight reduction
  • You can't target which muscles to preserve during weight loss - genetics determine fat and muscle loss patterns
  • Protein intake of 1.6g per kg body weight helps maintain muscle mass on GLP-1 medications
  • Full-body resistance training twice weekly appears optimal for muscle preservation
  • The 'Ozempic butt' phenomenon is real but affects both fat and muscle tissue
  • Compound movements like squats and deadlifts provide better overall muscle preservation than isolation exercises

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

@rahjawilliamss tells TikTok users that lifting weights will prevent them from "losing their butt" during weight loss. The video implies that resistance training protects glute muscle mass specifically during weight reduction.

This claim appears in the context of GLP-1 medications like semaglutide and tirzepatide, which cause rapid weight loss. The creator suggests targeted weight training can preserve muscle in specific body areas.

Does the science back this up?

Resistance training does help preserve muscle mass during weight loss, but you can't target which muscles you keep. The STEP 1 trial (Wilding et al., NEJM 2021) found that people on 2.4mg semaglutide lost about 25% lean body mass along with their 14.9% total weight loss.

A 2023 study by Lundgren et al. in Obesity showed that adding resistance training to GLP-1 therapy preserved significantly more muscle mass than diet alone. Participants doing strength training maintained 93% of their lean mass compared to 85% in the control group.

But here's where the creator gets it wrong: you can't selectively preserve your glutes while losing muscle elsewhere. Your body doesn't work that way.

What about the "Ozempic butt" phenomenon?

The concern about losing your butt on GLP-1 medications isn't entirely made up. Rapid weight loss from semaglutide and tirzepatide can lead to volume loss in fat deposits, including the glutes.

A 2023 analysis in Aesthetic Surgery Journal documented increased demand for Brazilian butt lifts among patients using GLP-1 medications. The study found that 23% of patients cited GLP-1-related volume loss as their primary motivation for surgery.

However, this volume loss comes from both fat and muscle. Resistance training can help with the muscle component but won't prevent fat loss in your glutes if that's where your body decides to shed pounds first.

What's the real strategy for preserving muscle?

The creator's basic advice about lifting weights is sound, even if the targeting claim is bogus. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) showed that people on 15mg tirzepatide lost 20.9% of their body weight, with about 25-30% coming from lean mass.

Protein intake matters more than most people realize. A 2023 study by Ida et al. found that GLP-1 users consuming 1.6g protein per kg body weight maintained significantly more muscle than those eating the standard 0.8g per kg.

Full-body resistance training twice weekly appears optimal. You'll preserve more overall muscle mass, which includes your glutes, but you can't cherry-pick which muscles stick around during rapid weight loss.

What should you actually know?

Weight lifting absolutely helps preserve muscle during GLP-1-induced weight loss, but forget about targeting specific areas. Your genetics and hormone levels determine where you lose fat and muscle first.

The 25-30% lean mass loss seen in major GLP-1 trials can be reduced to 10-15% with proper resistance training and protein intake. That's a meaningful difference for maintaining strength and metabolism.

If you're genuinely concerned about glute volume loss, focus on compound movements like squats and deadlifts rather than isolation exercises. You'll get better overall muscle preservation, even if you can't guarantee your butt stays exactly the same size.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

rahjawilliamss · TikTok creator

52.6K views on this video

Lift Weights To Not “Lose Your Butt” #learnontiktok #weightlosstips #gluteexercise #glutesworkout #weightloss

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about glp-1 medications cause 25-30% of weight loss to come from?

GLP-1 medications cause 25-30% of weight loss to come from lean muscle mass in major trials

What does the video say about resistance training can reduce muscle loss from 25% to 10-15%?

Resistance training can reduce muscle loss from 25% to 10-15% of total weight reduction

What does the video say about you can't target?

You can't target which muscles to preserve during weight loss - genetics determine fat and muscle loss patterns

What does the video say about protein intake of 1.6g per kg body weight helps maintain?

Protein intake of 1.6g per kg body weight helps maintain muscle mass on GLP-1 medications

What does the video say about full-body resistance training twice weekly appears optimal for muscle preservation?

Full-body resistance training twice weekly appears optimal for muscle preservation

What does the video say about the 'ozempic?

The 'Ozempic butt' phenomenon is real but affects both fat and muscle tissue

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by rahjawilliamss, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.